Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Cerilliant
Harvard Business School
Daiichi Sankyo
Merck
Express Scripts
Fish and Richardson
Fuji

Generated: June 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020090

« Back to Dashboard

NDA 020090 describes DIFLUCAN, which is a drug marketed by Pfizer and is included in three NDAs. It is available from six suppliers. Additional details are available on the DIFLUCAN profile page.

The generic ingredient in DIFLUCAN is fluconazole. There are twenty-three drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the fluconazole profile page.
Summary for 020090
Tradename:DIFLUCAN
Applicant:Pfizer
Ingredient:fluconazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020090
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIFLUCAN fluconazole FOR SUSPENSION;ORAL 020090 NDA Roerig 0049-3440 N 0049-3440-19
DIFLUCAN fluconazole FOR SUSPENSION;ORAL 020090 NDA Roerig 0049-3450 N 0049-3450-19

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength50MG/5ML
Approval Date:Dec 23, 1993TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength200MG/5ML
Approval Date:Dec 23, 1993TE:ABRLD:Yes

Expired US Patents for NDA 020090

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer DIFLUCAN fluconazole FOR SUSPENSION;ORAL 020090-001 Dec 23, 1993 ➤ Sign Up ➤ Sign Up
Pfizer DIFLUCAN fluconazole FOR SUSPENSION;ORAL 020090-002 Dec 23, 1993 ➤ Sign Up ➤ Sign Up
Pfizer DIFLUCAN fluconazole FOR SUSPENSION;ORAL 020090-001 Dec 23, 1993 ➤ Sign Up ➤ Sign Up
Pfizer DIFLUCAN fluconazole FOR SUSPENSION;ORAL 020090-002 Dec 23, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Argus Health
Harvard Business School
Mallinckrodt
Merck
Queensland Health
Baxter
Boehringer Ingelheim
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.